PRAME and nevus: Immunoreactivity for PRAME was seen, albeit usually only in a minor subpopulation of lesional melanocytes, in 13.6% of cutaneous nevi, including dysplastic nevi, common acquired nevi, traumatized and recurrent nevi, and Spitz nevi (one case in a 6 years-old child).